Drugs / Dihydroxypropyltheophylline
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04810819 | Jul → Oct 2021 | — | Qianfoshan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dihydroxypropyltheophylline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04810819 ↗ |
| Route | Intravenous | “0.25 g dihydroxypropyltheophylline and 100 ml normal saline were given intravenously” NCT04810819 ↗ |